Impact of body mass index, metabolic health and weight change on incident diabetes in a Korean population

Obesity

Volumn 22, Issue 8, 2014, Pages 1880-1887

  Jung, Hyun Suk ^a   Chang, Yoosoo ^a   Eun Yun, Kyung ^a   Kim, Chan Won ^a   Choi, Eun Suk ^a   Kwon, Min Jung ^a   Cho, Juhee ^a,b   Zhang, Yiyi ^c,d   Rampal, Sanjay ^c,d,e   Zhao, Di ^c,d   Soo Kim, Hyun ^a   Shin, Hocheol ^a   Guallar, Eliseo ^c,d   Ryu, Seungho ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b Sungkyunkwan University   (South Korea)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF MALAYA   (Malaysia)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; C REACTIVE PROTEIN; CHOLESTEROL; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DIET RESTRICTION; DISEASE ASSOCIATION; EXERCISE; FATTY LIVER; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HEALTH HAZARD; HEALTH STATUS; HIGH RISK PATIENT; HOMEOSTASIS; HUMAN; HYPERTENSION; INCIDENCE; INSULIN RESISTANCE; KOREAN (PEOPLE); MAJOR CLINICAL STUDY; MALE; MASS SCREENING; METABOLIC SYNDROME X; METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PHENOTYPE; SEX DIFFERENCE; SMOKING; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT CHANGE; ASIAN CONTINENTAL ANCESTRY GROUP; BODY WEIGHT; DIABETES MELLITUS, TYPE 2; MIDDLE AGED;

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; BODY MASS INDEX; BODY WEIGHT; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; INCIDENCE; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY;

EID: 84905034109     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1002/oby.20751     Document Type: Article

References (40)

1. Whiting DR, Guariguata L, Weil C, Shaw J,. IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabet Res Clin Pract 2011; 94: 311-321.
2. Yoon KH, Lee JH, Kim JW, et al. Epidemic obesity and type 2 diabetes in Asia. Lancet 2006; 368: 1681-1688.
3. Chan JC, Malik V, Jia W, et al. Diabetes in Asia: epidemiology, risk factors, and pathophysiology. JAMA 2009; 301: 2129-2140.
4. Ramachandran A, Ma RC, Snehalatha C,. Diabetes in Asia. Lancet 2010; 375: 408-418.
5. Razak F, Anand SS, Shannon H, et al. Defining obesity cut points in a multiethnic population. Circulation 2007; 115: 2111-2118.
6. Wen CP, David Cheng TY, et al. Are Asians at greater mortality risks for being overweight than Caucasians? Redefining obesity for Asians. Public Health Nutr 2009; 12: 497-506.
7. Shai I, Jiang R, Manson JE, et al. Ethnicity, obesity, and risk of type 2 diabetes in women: a 20-year follow-up study. Diabet Care 2006; 29: 1585-1590.
8. Ruderman N, Chisholm D, Pi-Sunyer X, Schneider S, the metabolically obese, normal-weight individual revisited. Diabetes 1998; 47: 699-713.
9. Chang Y, Ryu S, Suh BS, Yun KE, Kim CW, Cho SI,. Impact of BMI on the incidence of metabolic abnormalities in metabolically healthy men. Int J Obes (Lond) 2012; 36: 1187-1194.
10. Chang Y, Ryu S, Sung E, Jang Y,. Higher concentrations of alanine aminotransferase within the reference interval predict nonalcoholic fatty liver disease. Clin Chem 2007; 53: 686-692.
11. Chang Y, Jung HS, Yun KE, Cho J, Cho YK, Ryu S,. Cohort study of non-alcoholic fatty liver disease, NAFLD fibrosis score, and the risk of incident diabetes in a Korean population. Am J Gastroenterol 2013; 108: 1861-1868.
12. Chang Y, Yun KE, Jung HS, et al. A1C and coronary artery calcification in nondiabetic men and women. Arteriosclerosis Thromb Vasc Biol 2013; 33: 2026-2031.
13. Alberti KG, Eckel RH, Grundy SM, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009; 120: 1640-1645.
14. Kuk JL, Ardern CI,. Are metabolically normal but obese individuals at lower risk for all-cause mortality? Diabet Care 2009; 32: 2297-2299.
15. Primeau V, Coderre L, Karelis AD, et al. Characterizing the profile of obese patients who are metabolically healthy. Int J Obes (Lond) 2011; 35: 971-981.
16. Mathiesen UL, Franzen LE, Aselius H, et al. Increased liver echogenicity at ultrasound examination reflects degree of steatosis but not of fibrosis in asymptomatic patients with mild/moderate abnormalities of liver transaminases. Dig Liver Dis 2002; 34: 516-522.
17. WHO Western Pacific Region IaI the Asia-Pacific perspective: redefining obesity and its treatment. Sydney, Australia: Health Communications Australia Pty Ltd; 2000.
18. Royston P, Parmar MK,. Flexible parametric proportional-hazards and proportional-odds models for censored survival data, with application to prognostic modelling and estimation of treatment effects. Stat Med 2002; 21: 2175-2197.
19. D'Agostino RB, Lee ML, Belanger AJ, Cupples LA, Anderson K, Kannel WB,. Relation of pooled logistic regression to time dependent Cox regression analysis: the Framingham Heart Study. Stat Med 1990; 9: 1501-1515.
20. Pearson TA, Mensah GA, Alexander RW, et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 2003; 107: 499-511.
21. Meigs JB, Wilson PW, Fox CS, et al. Body mass index, metabolic syndrome, and risk of type 2 diabetes or cardiovascular disease. J Clin Endocrinol Metab 2006; 91: 2906-2912.
22. Arnlov J, Sundstrom J, Ingelsson E, Lind L,. Impact of BMI and the metabolic syndrome on the risk of diabetes in middle-aged men. Diabetes Care 2011; 34: 61-65.
23. Appleton SL, Seaborn CJ, Visvanathan R, et al. Diabetes and cardiovascular disease outcomes in the metabolically healthy obese phenotype: a cohort study. Diabet Care 2013; 36: 2388-2394.
24. Sakurai Y, Teruya K, Shimada N, et al. Relationship between weight change in young adulthood and the risk of NIDDM the Sotetsu Study. Diabet Care 1997; 20: 978-982.
25. Ishikawa-Takata K, Ohta T, Moritaki K, Gotou T, Inoue S,. Obesity, weight change and risks for hypertension, diabetes and hypercholesterolemia in Japanese men. Eur J Clin Nutr 2002; 56: 601-607.
26. Nanri A, Mizoue T, Takahashi Y, et al. Association of weight change in different periods of adulthood with risk of type 2 diabetes in Japanese men and women: the Japan Public Health Center-Based Prospective Study. J Epidemiol Commun Health 2011; 65: 1104-1110.
27. Chan JM, Rimm EB, Colditz GA, Stampfer MJ, Willett WC,. Obesity, fat distribution, and weight gain as risk factors for clinical diabetes in men. Diabet Care 1994; 17: 961-969.
28. Colditz GA, Willett WC, Rotnitzky A, Manson JE,. Weight gain as a risk factor for clinical diabetes mellitus in women. Ann Intern Med 1995; 122: 481-486.
29. Ford ES, Williamson DF, Liu S,. Weight change and diabetes incidence: findings from a national cohort of US adults. Am J Epidemiol 1997; 146: 214-222.
30. Wannamethee SG, Shaper AG,. Weight change and duration of overweight and obesity in the incidence of type 2 diabetes. Diabet Care 1999; 22: 1266-1272.
31. Koh-Banerjee P, Wang Y, Hu FB, Spiegelman D, Willett WC, Rimm EB,. Changes in body weight and body fat distribution as risk factors for clinical diabetes in US men. Am J Epidemiol 2004; 159: 1150-1159.
32. Oguma Y, Sesso HD, Paffenbarger RS Jr, Lee IM,. Weight change and risk of developing type 2 diabetes. Obes Res 2005; 13: 945-951.
33. Mishra GD, Carrigan G, Brown WJ, Barnett AG, Dobson AJ,. Short-term weight change and the incidence of diabetes in midlife: results from the Australian Longitudinal Study on Women's Health. Diabet Care 2007; 30: 1418-1424.
34. Resnick HE, Valsania P, Halter JB, Lin X,. Relation of weight gain and weight loss on subsequent diabetes risk in overweight adults. J Epidemiol Commun Health 2000; 54: 596-602.
35. Tam CS, Viardot A, Clement K, et al. Short-term overfeeding may induce peripheral insulin resistance without altering subcutaneous adipose tissue macrophages in humans. Diabetes 2010; 59: 2164-2170.
36. Erdmann J, Kallabis B, Oppel U, Sypchenko O, Wagenpfeil S, Schusdziarra V,. Development of hyperinsulinemia and insulin resistance during the early stage of weight gain. Am J Physiol Endocrinol Metab 2008; 294: E568-E575.
37. Hill A, Roberts J,. Body mass index: a comparison between self-reported and measured height and weight. J Public Health Med 1998; 20: 206-210.
38. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabet Care 2010; 33 (Suppl 1): S62-S69.
39. Abdullah A, Wolfe R, Stoelwinder JU, et al the number of years lived with obesity and the risk of all-cause and cause-specific mortality. Int J Epidemiol 2011; 40: 985-996.
40. Abdullah A, Stoelwinder J, Shortreed S, et al the duration of obesity and the risk of type 2 diabetes. Public Health Nutr 2011; 14: 119-126.